Seelaus Asset Management LLC Abbott Laboratories Transaction History

Seelaus Asset Management LLC

$104 Million
Q4 2024

A detailed history of Seelaus Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Seelaus Asset Management LLC holds 5,853 shares of ABT stock, worth $748,774. This represents 0.64% of its overall portfolio holdings.

Number of Shares

5,853

Previous 5,940 1.46%

Holding current value

$748,774

Previous $677,000 2.22%

% of portfolio

0.64%

Previous 0.66%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$111.93 - $119.39 $9,737 - $10,386	-87 Reduced 1.46%	5,853 $662,000
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $49,861 - $55,657	-495 Reduced 7.69%	5,940 $617,000
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $4,960 - $6,072	-55 Reduced 0.85%	6,435 $708,000
Q3 2023 Nov 16, 2023	SELL	$95.53 - $114.62 $2,865 - $3,438	-30 Reduced 0.46%	6,490 $628,000
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $45,351 - $50,530	-450 Reduced 6.46%	6,520 $711,000
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $56,856 - $66,923	587 Added 9.2%	6,970 $726,000
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $19,012 - $22,304	200 Added 3.23%	6,383 $701,000
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $106,608 - $130,002	-935 Reduced 13.14%	6,183 $732,000
Q4 2021 Jan 10, 2022	SELL	$115.53 - $141.46 $39,742 - $48,662	-344 Reduced 4.61%	7,118 $1 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $16,565 - $18,326	-142 Reduced 1.87%	7,462 $881,000
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $3,173 - $3,735	30 Added 0.4%	7,604 $882,000
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $13,060 - $15,387	-120 Reduced 1.56%	7,574 $908,000
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $33,075 - $36,042	315 Added 4.27%	7,694 $842,000
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $2,382 - $2,893	-26 Reduced 0.35%	7,379 $803,000
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $36,294 - $46,452	-474 Reduced 6.02%	7,405 $677,000
Q1 2020 May 04, 2020	SELL	$62.82 - $91.86 $7,538 - $11,023	-120 Reduced 1.5%	7,879 $622,000
Q4 2019 Jan 31, 2020	BUY	$78.51 - $87.4 $27,557 - $30,677	351 Added 4.59%	7,999 $695,000
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $4,583 - $4,969	-56 Reduced 0.73%	7,648 $640,000
Q2 2019 Jul 31, 2019	BUY	$72.88 - $85.0 $7,288 - $8,500	100 Added 1.32%	7,704 $648,000
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $3,933 - $4,456	-60 Reduced 0.78%	7,604 $550,000
Q3 2018 Oct 23, 2018	SELL	$60.81 - $73.36 $21,891 - $26,409	-360 Reduced 4.49%	7,664 $562,000
Q2 2018 Jul 18, 2018	SELL	$57.57 - $63.54 $29,187 - $32,214	-507 Reduced 5.94%	8,024 $489,000
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $73,094 - $82,642	1,299 Added 17.96%	8,531 $511,000
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $388,213 - $415,623	7,232	7,232 $413,000

Others Institutions Holding ABT

# of Institutions

3,224

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seelaus Asset Management LLC with notifications on news.

Account

Seelaus Asset Management LLC Abbott Laboratories Transaction History